Sacote, Enecito P.

HRN: 23-58-50  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/22/2023
08/29/2023
IV
1.5gms
Q6
Cellulitis
Waiting Final Action 
08/22/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/22/2023
08/29/2023
IV
600mg
Q6
Cellulitis
Waiting Final Action 
08/28/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/28/2023
09/10/2023
IV
600mg
Q6
Osteomyelitis
Waiting Final Action 
08/28/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/28/2023
09/10/2023
IV
1.5g
Q12
Osteomyelitis
Waiting Final Action 
09/07/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
09/07/2023
09/13/2023
TOPICAL
1%
TID
Cellulitis, Right Forearm
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: